Advocacy and Healthcare Improvement
As a leader in advocacy for safe medication practices, ISMP undertakes numerous pro-bono activities designed to influence, inform, and drive positive change the healthcare community.
Some of our most influential advocacy activities include the following:
- Interaction with the U.S. Food and Drug Administration on crucial safety issues
- Helping advocate for safe medication use with legislators and policy makers
- Participation in safety-related panels, committees, and councils, including with the following organizations:
- Institute of Medicine
- International Medication Safety Network
- Joint Commission
- National Coordinating Council for Medication Error Reporting and Prevention
- National Quality Forum
- United States Pharmacopeia
- World Health Organization
- Holding national summits to gain consensus on emerging safety challenges
- Publishing white papers, guidelines, recommendations, and self assessments on risk prevention
- Offering free consultations on safety issues for students and healthcare practitioners
- Persuading pharmaceutical manufacturers to correct naming, labeling, and packaging problems
- Operating Medication Safety Officers Society (MSOS) for professionals interested in error prevention
- Reviewing standards and guidelines developed by other healthcare and accrediting organizations
- Conducting awareness campaigns to increase knowledge about error prevention
Contribute to a Safer Future
We depend on your support so we can conduct in-depth investigations and disseminate valuable safety information to healthcare facilities. Your financial contribution can make a world of difference.